Joint Pain Injections Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts

The Joint Pain Injections Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Joint Pain Injections Market Size During the Forecast Period?
There has been a swift expansion in the market for joint pain injections in the last few years. The market, which is projected to rise from $5.6 billion in 2024 to $6.17 billion in 2025, would witness a compound annual growth rate (CAGR) of 10.1%. The historic period's growth can be credited to factors including the surge in the elderly population, incidence of arthritis, initiatives for global health, digital transformation in healthcare, and growing awareness regarding management of chronic pain.

The market size of joint pain injections is predicted to experience swift expansion in the forthcoming years. The market is forecasted to reach $9.81 billion in 2029, growing at a compound annual growth rate (CAGR) of 12.3%. The surge during the forecast period can be due to the widespread adoption of telehealth services, individualized pain management, enlightening and enabling patients, sustainable healthcare methodologies, and nutritional aid. The key trends that will shape the forecast period are regenerative medicine, bespoke pain management, new injection materials, restoration technologies, and AI-powered injections.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6482

What Are the High-Growth Segments in the Joint Pain Injections Market?
The joint pain injections market covered in this report is segmented -

1) By Type Of Injection: Steroid Joint Injection, Hyaluronic Acid Injections, Platelet-Rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Other Type Of Injections
2) By Joint Type: Hip Joint, Knee And Ankle, Shoulder And Elbow, Facet Joints Of The Spine, Other Joint Types
3) By Distribution channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Steroid Joint Injection: Corticosteroid Injections, Combination Steroid Injections
2) By Hyaluronic Acid Injections: Single-Dose Hyaluronic Acid Injections, Multi-Dose Hyaluronic Acid Injections
3) By Platelet-Rich Plasma (PRP) Injections: Autologous PRP Injections, Allogeneic PRP Injections
4) By Placental Tissue Matrix (PTM) Injections: Amniotic Fluid Injections, Placental Derived Cell Injections
5) By Other Types of Injections: Bone Marrow Aspirate Concentrate (BMAC) Injections, Stem Cell Injections, Genetically Engineered Cell Injections

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6482&type=smp

What Key Drivers Are Expected to Influence Future Joint Pain Injections Market Growth?
The growth of the joint pain injections market is being fueled by an increase in both arthritis and musculoskeletal conditions. Through this increase, musculoskeletal ailments have become the largest source of disability globally, with low back pain ranking as the foremost cause of impairment across 160 countries. With a need for relief from pain and inflammation, patients are increasingly resorting to injections. For example, the Australian Institute of Health and Welfare, a government agency from Australia, reported in June 2023 that rheumatoid arthritis accounted for 2.0% of the total disease burden and contributed to 16% of the overall musculoskeletal-related disease burden. In 2022, this condition resulted in 1,322 fatalities, equating to 5.1 deaths per 100,000 people, and formed 0.7% of all deaths. As such, the escalating occurrence of arthritis and musculoskeletal ailments is generating a demand in the joint pain injections market.

Which Companies Hold the Largest Share Across Different Joint Pain Injections Market Segments?
Major companies operating in the joint pain injections market include Seikagaku Corporation, Flexion Therapeutics Inc., Zimmer Biomet Holdings Inc., Sanofi S.A., Anika Therapeutics Inc., Abbvie Inc., Bioventus Inc., Eli Lilly and Company, Ferring Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Johnson & Johnson Services Ltd., Merck & Co. Inc., GlaxoSmithKline plc, Novartis AG, AstraZeneca plc, Roche Holding AG, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Bayer AG, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen SA, Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., Zydus Lifesciences Limited

What Trends Are Driving Growth in The Joint Pain Injections Market?
Companies prominent in the joint pain injection market are zeroing in on creating breakthroughs such as single-injection formulations for the convenience of patients. Single-injection formulations are a unique kind of drug delivery method developed to deliver a certain dosage of medication with one injection, maintaining prolonged therapeutic impact without the necessity for multiple dosages. As an example, July 2024 saw LG Chem Ltd., a chemical firm based in South Korea, introducing Synovian, a novel treatment for knee osteoarthritis in China, featuring a convenient single-injection formulation, establishing it as a pioneer in the nation. The product is tuned to tap into a considerable market valued approximately at KRW 200 billion (equivalent to USD 150 million). Its development, based on exclusive technology, illustrates an innovative approach in meeting the needs of patients, aiming at granting substantial relief with minimal administration effort.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

What Are the Emerging Geographies for The Joint Pain Injections Market Growth?
North America was the largest region in the joint pain injections market in 2024. The regions covered in the joint pain injections market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Joint Pain Injections Market?
2. What is the CAGR expected in the Joint Pain Injections Market?
3. What Are the Key Innovations Transforming the Joint Pain Injections Industry?
4. Which Region Is Leading the Joint Pain Injections Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.